Topics

Recommendations for Under-Representation of African Americans in Multiple Myeloma

19:00 EST 13 Feb 2020 | Cancer Networks

In a workshop conducted by the FDA and the AACR, working groups came together to address disparities in the representation of African Americans in multiple myeloma clinical trials and to create a set of recommendations in an attempt resolve them.

Original Article: Recommendations for Under-Representation of African Americans in Multiple Myeloma

NEXT ARTICLE

More From BioPortfolio on "Recommendations for Under-Representation of African Americans in Multiple Myeloma"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...